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ABSTRACT
HIV testing and counselling forms the gateway to the HIV care and treatment continuum. Therefore,
the World Health Organization recommends provider-initiated testing and counselling (PITC) in
countries with a generalized HIV epidemic. Few studies have investigated linkage-to-HIV-care
among out-patients after PITC. Our objective was to study timely linkage-to-HIV-care in six
Rwandan health facilities (HFs) before and after the introduction of PITC in the out-patient
departments (OPDs). Information from patients diagnosed with HIV was abstracted from
voluntary counselling and testing, OPD and laboratory registers of six Rwandan HFs during
three-month periods before (March–May 2009) and after (December 2009–February 2010) the
introduction of PITC in the OPDs of these facilities. Information on patients’ subsequent linkage-
to-pre-antiretroviral therapy (ART) care and ART was abstracted from ART clinic registers of each
HF. To triangulate the findings from HF routine, a survey was held among patients to assess
reasons for non-enrolment. Of 635 patients with an HIV diagnosis, 232 (36.5%) enrolled at the
ART clinic within 90 days of diagnosis. Enrolment among out-patients decreased after the
introduction of PITC (adjusted odds ratio, 2.0; 95% confidence interval, 1.0–4.2; p = .051). Survey
findings showed that retesting for HIV among patients already diagnosed and enrolled into care
was not uncommon. Patients reported non-acceptance of disease status, stigma and problems
with healthcare services as main barriers for enrolment. Timely linkage-to-HIV-care was
suboptimal in this Rwandan study before and after the introduction of PITC; the introduction of
PITC in the OPD may have had a negative impact on linkage-to-HIV-care. Healthier patients
tested through PITC might be less ready to engage in HIV care. Fear of HIV stigma and mistrust
of test results appear to be at the root of these problems.
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Introduction
The increase in access to antiretroviral therapy (ART) in
Sub-Saharan Africa (SSA) is a success story in the history
of the HIV epidemic (World Health Organization
[WHO], 2013). ART has proven effective in reducing
mortality rates among people infected with HIV (Palella
et al., 1998), as well as reducing vertical (De Cock et al.,
2000; Siegfried, van der Merwe, Brocklehurst, & Sint,
2011) and horizontal transmission rates (Cohen et al.,
2011). Therefore, the WHO recommends provider-
initiated testing and counselling (PITC) in countries
with an HIV prevalence of 3.0% or higher (WHO,
2007). HIV testing and counselling forms the gateway
to the care and treatment continuum (McNairy & El
Sadr, 2012). However, only one-third to two-thirds of
patients with a new HIV diagnosis are tested for CD4
or return for results within three months of the HIV
test in SSA (Kranzer, Govindasamy, Ford, Johnston, &
Lawn, 2012; Rosen & Fox, 2011). Transport costs and
distance to clinic, as well as stigma and fear of disclosure
are common barriers towards linkage-to-HIV-care
(Govindasamy, Ford, & Kranzer, 2012; Lankowski,
Siedner, Bangsberg, & Tsai, 2014).
Rwanda is a densely populated country, with an adult
HIV seroprevalence rate of 3.0% (National Institute of
Statistics of Rwanda [NISR], 2012). The prevalence is
higher in urban (7.1%) than rural areas (2.3%) (NISR,
2012). ART is available in 93% of hospitals and 29% of
health centres (HCs) (NISR, 2008). In 2005, the Demo-
graphic and Health survey of Rwanda reported that
around 80% of adults had not been tested for HIV
(NISR, 2006). The Ministry of Health therefore
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recommended introducing PITC in all its health facilities
(HFs) in 2008. At the start of the study, PITC was already
running with high uptake rates among antenatal women
and tuberculosis (TB) patients. PITC was not practised
in out-patient departments (OPDs); HIV testing was
only performed when out-patients presented with symp-
toms of HIV infection.
PITC has increased ART uptake in antenatal care
clinics in SSA (Hensen et al., 2012). Fewer studies have
investigated linkage-to-HIV-care among out-patients
after PITC (Kennedy et al., 2013; Roura, Watson-Jones,
Kahawita, Ferguson, & Ross, 2013). In this study, a
PITC intervention was introduced in OPDs of six Rwan-
dan HFs. The objective of this study was to examine link-
age-to-HIV-care (pre-ART, eligibility for ART and start
of ART) before and after the introduction of a PITC
intervention in the OPD. As patients who attend the
OPD for a purpose other than getting an HIV test
might be less motivated to seek HIV care than patients
specifically coming for HIV testing, we hypothesized
that linkage-to-HIV-care at the OPD would be lower
after the introduction of PITC.
Methods
Setting
The current study was part of a cluster non-randomized
controlled trial that investigated the HIV testing uptake
and acceptability of introducing a PITC intervention in
OPDs of Rwandan HFs (Kayigamba et al., 2012, 2014).
Eight Rwandan HFs were purposefully selected for this
trial, ensuring inclusion of urban and rural HFs and suffi-
cient numbers of attendees. All these HFs had a complete
range of HIV testing, care, and treatment activities in
place. All HFs had an OPD, where routine PITC was
not yet practised at the start of the study. HFswere located
in the Musanze district in the north-west of Rwanda
(Ruhengeri hospital,MuhozaHC, RwazaHC, and control
site Gasiza HC) and in the Gasabo district surrounding
the capital Kigali (Kibagabaga hospital, Kimironko HC,
Kinyinya HC, and control site Kabuye HC).
This study investigated linkage-to-HIV-care before
and after the introduction of a PITC intervention. The
following stages were investigated: (1) linkage-to-pre-
ART-care (we studied how many patients registered at
the HFs ART clinic within 90 days of HIV diagnosis);
(2) eligibility for ART (at the time of the study, HIV-
infected patients were eligible for ART when CD4
count was <350 cells/mm3 or they were in WHO clinical
stage 4; TB was classified as WHO stage 3 (Trac-plus,
2009)); and (3) start of ART (we studied how many eli-
gible patients started ART within 90 days of HIV
diagnosis). This study is a sub-analysis of data from
the OPDs and voluntary counselling and testing (VCT)
departments of the six HFs that implemented the inter-
vention. Data from VCT departments were included in
order to examine whether linkage-to-HIV-care among
out-patients differed from VCT patients and to detect
seasonal effects. Due to low numbers of HIV cases in
the two control HFs, these could not serve as control
sites for the purpose of the current study and were there-
fore excluded (Kayigamba et al., 2012). Characteristics of
the HFs included in this study are described in Table S1.
The intervention
The intervention consisted of three phases: in phase 1
(March–May 2009) PITC was not operational in
OPDs. In phase 2 (June–November 2009) healthcare
workers (HCWs) were trained to offer PITC and pro-
vided materials, administer HIV testing, and use registers
adapted for the study to record details of testing. In phase
3 (December 2009–February 2010) PITC was fully oper-
ational in the OPDs. Patients in OPDs were systemati-
cally offered an HIV test on an opt-out basis. We
anticipated that this new intervention would increase
workload and responsibility for HCW; accordingly we
provided salary top-ups to department heads and sti-
pends to HCW.
Data collection
At each HF, patients who were diagnosed with HIV were
referred to the ART clinic of that HF, with the exception
of one clinic (Muhoza), from where patients were
referred to the neighbouring Ruhengeri hospital. At the
ART clinic each patient was examined by a physician,
the WHO stage was established, and a blood sample
was taken to measure the CD4 count. Information on
patients’ subsequent linkage-to-pre-ART care and ART
was abstracted from ART clinic registers of each HF.
Information from patients diagnosed with HIV was
abstracted from VCT, OPD, and laboratory registers of
six Rwandan HFs during three-month periods before
(March–May 2009) and after (December 2009–February
2010) the introduction of PITC in the OPDs of these
HFs. Data collection and hospital routine have been
described in detail before (Kayigamba et al., 2012).
Survey
We conducted a survey in order to identify patient-
reported barriers towards linkage-to-HIV-care. We
interviewed a convenience sample of patients from
each HF aged 18 years or above who were diagnosed
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with HIV in phase 3 and did not enrol within 90 days.
The survey was done in August 2010 at patients’
homes. For this survey, a questionnaire was developed
that included closed questions on demographic charac-
teristics of the patient, whether the patient enrolled
into care at the time of the survey and, if so, into
which HF, and a final open-ended question about his/
her reason(s) for not enrolling into HIV care. The ques-
tions were read to patients in Kinyarwanda by trained
interviewers. Answers were written down on the ques-
tionnaire form and later translated into English by a
trained translator.
Data analysis
We used STATA software release 11 (StataCorp, College
Station, TX, USA) for all quantitative analyses. Associ-
ations between four explanatory variables (department
by phase, site, sex, and age) and five outcomes (enrol-
ment into pre-ART care; advanced WHO stage; CD4
count; ART eligibility; and start of ART) were assessed
using the chi-squared test, Fisher’s exact test or Krus-
kal–Wallis test, as appropriate. Multivariable logistic
regression analyses were done to identify factors associ-
ated with non-enrolment into pre-ART care, advanced
clinical disease stage (WHO stage 3 or 4), ART eligibility,
and not starting ART. All explanatory variables were
included in multivariable models a priori. p Values of
<.05 were considered statistically significant. Time
from HIV diagnosis to enrolment into pre-ART care
and to start of ART, and time from CD4 count to start
of ART were examined with Kaplan–Meier graphs.
Answers to the open-ended survey question regard-
ing reasons for non-enrolment in pre-ART care were
read multiple times and coded by a researcher (CF)
using principles of thematic analysis (Boyatzis, 1998).
When concepts or statements were unclear, the mean-
ing of words in Kinyarwanda was discussed with the
translator. Codes were categorized into overarching
themes by discussing the findings among the authors
(CF, KM, MB, and FK) and reviewing the existing lit-
erature on commonly reported barriers towards link-
age-to-HIV-care.
Ethics
Ethical approval was provided by the Rwandan National
Ethics Committee and the research ethics committee of
the Academic Medical Center, Amsterdam. Permission
for home visits and written informed consent was
obtained from all patients.
Results
Patients diagnosed with HIV
In phases 1 and 3 of the study, 722 patients were diag-
nosed with HIV; children below 15 years (n = 23) were
excluded, as were 64 patients due to missing names or
codes (Figure 1), leaving 635 patients in the analysis.
Most patients were female (61.7%) and the median age
was 30 years (interquartile range (IQR) 24–38). In phase 1,
73patients (23.5%)were diagnosed at theOPD. Inphase 3,
the number and the relative share of patients diagnosed at
the OPD increased (125; 38.5%). Between 13 and 255 per-
sons were diagnosed at each individual site.
Linkage-to-pre-ART-care
Among the 635 patients, 232 (36.5%) enrolled into pre-
ART care during phases 1 and 3 combined (Figure 1).
There was no significant difference in enrolment by sex
or age (Table 1), but enrolment varied strongly by study
site: Muhoza had the lowest enrolment (23.5%), and
Rwaza the highest (55.6%; p < .001). Among VCT
patients, enrolment remained relatively constant during
phases 1 and 3 (38.3%and35.5%, respectively). Enrolment
among out-patients was slightly higher than among VCT
patients during phase 1 (43.8%), but enrolment among
out-patients was lower during phase 3 (29.6%). The differ-
ence between enrolment among out-patients in phases 1
and 3 was significant in univariable, but not in multivari-
able analysis (adjusted odds ratio (aOR), 2.0; 95% confi-
dence interval (CI), 1.0–4.2; p = .051, Table 2).
Of the 232 patients enrolled into pre-ART care, 169
(74.6%) had done so 14 days after HIV diagnosis, and
205 (88.4%) after 30 days (Figure 2(a)). Among those
who enrolled, the median time to enrolment was 6
days (IQR 2–15). Median time to enrolment in phase 1
was 3.5 days (IQR 1–13.5) among VCT patients, and 9
days (IQR 4.5–20.5) among out-patients. This was simi-
lar in phase 3 (4 days (IQR 2–10) and 9 days (IQR 4–19),
respectively).
Art eligibility
Of the 232 patients enrolled in pre-ART care, WHO sta-
ging was available for 217 (93.5%) patients. Of these,
19.8% were in WHO stage 3 and none were in stage 4
(Table 1). This was similar for men and women (20.9%
and 19.1%, respectively). Only study site was signifi-
cantly associated with high WHO stage in univariable
and multivariable analysis (Table S2).
CD4 count was available for 218 patients (94.0%).
Median CD4 count was 384 cells/mm3 (IQR, 214–539;
Table 1). CD4 counts were significantly lower among
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men and older patients (p = .003 and p = .011, respect-
ively). Among out-patients, the median CD4 count was
287 cells/mm3 in phase 1 and 312 cells/mm3 in phase 3
and among VCT patients, the median CD4 count was
398 cells/mm3 in phase 1 and 431 cells/mm3 in phase 3
(p = .008). CD4 counts did not differ significantly
between sites (Table 1).
Both CD4 count and WHO staging were available for
89.7% (208/232) of patients. Of these, 93 (44.7%) were
eligible for ART (Table 1). ART eligibility was fully
dependent on a low CD4 count (<350 cells/mm3) as
none of the patients were classified in WHO stage
4. Only sex was significantly associated with ART eligi-
bility (p = .017), with men being more often eligible for
ART than women (aOR 1.9; 95% CI 1.0–3.5; Table S3).
Start of ART
Of the 93 patients eligible for ART, 48 (51.6%) started
ART within 90 days of HIV diagnosis (Figure 1).
Among the 48 patients who started ART the median
time between HIV diagnosis and start of ART was 35.5
days (IQR 17–60), and between CD4 count and start of
ART 27 days (IQR 12.5–50) (Figure 2(b and c)). The pro-
portions of patients starting ART varied significantly by
study site (Tables 1 and S4). Due to small numbers, we
did not perform multivariable analysis.
Survey results
In total, 60 patients (34 VCT patients and 26 out-
patients) – who had not been enrolled into pre-ART
care in phase 3 of the study – were interviewed for the
survey (76% of the approached patients). The main
reason for non-interview was that the patient had
moved or could not be found at the provided address
at the time of interview.
The majority of patients 57% (34/60) were still not
enrolled into pre-ART care (Table 3). Of the patients
who did enrol, most (10/60, 17%) enrolled at a different
Figure 1. Flow of linkage-to-pre-ART-care and start of ART among HIV-infected patients, Rwanda, March–May 2009 (phase 1) and
December 2009–February 2010 (phase 3). ART = antiretroviral therapy and WHO =World Health Organization.
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HF then the one they were tested at, and only 2/60 (3%)
enrolled at the same HF. A large proportion of patients
(14/60, 23%) were already enrolled into pre-ART care
before they took an HIV test (a retest) in phase
3. Among VCT patients, 29% (10/34) had retested for
HIV and among out-patients 15% (4/26) had retested
for HIV (Table 3). VCT patients had retested for HIV
on their own initiative. Some patients who were already
taking ART mentioned taking a retest to assess whether
they had been cured by prayers. Out-patients had been
retested on request by the HCW at the OPD.
A reason for not enrolling into HIV care that was
often reported was not accepting or mistrusting one’s
positive HIV status (7/34, 21%). Some patients men-
tioned taking up to three or four tests at different facili-
ties to confirm the results. Patients often reported that
they did not want to return to the same clinic after an
HIV diagnosis, because of fear of being seen and stigma-
tized by people they knew (8/34, 24%). Some of the
patients who reported this reason had enrolled at a
different HF. Many patients (8/34, 24%) reported that
they did not enrol into HIV care because they encoun-
tered problems at the HF (Table 3). Specific reasons
given were: long waiting times, not being told, or not rea-
lizing, that they had to return for a follow-up, or failing
to find the HCW at the given follow-up appointment.
Some patients (5/34, 15%) mentioned that after an initial
positive result they were tested at a different HF and had
a negative HIV outcome there.
Discussion
In this study in six Rwandan HFs, timely linkage-to-pre-
ART-care and ART was suboptimal before and after the
introduction of PITC. We found that enrolment among
out-patients was lower after the implementation of
PITC, although this finding was not significant in multi-
variable analysis.
It is possible that under PITC, healthier out-patients
enrolled less often. As hypothesized, when coming to
the OPD for a different reason than to be tested for
HIV, some patients might be less ready to enrol into
HIV care; this may be especially the case for patients
without clear symptoms of HIV. Low perceived suscep-
tibility to HIV has been linked to treatment avoidance
(Nakigozi et al., 2013; Varni, Miller, McCuin, & Solo-
mon, 2012). This hypothesis is supported by the finding
that out-patients in this study who enrolled into pre-
ART care had lower absolute CD4 counts than VCT
patients both before and after the introduction of
Table 1. Linkage to pre-ART care, WHO stage, CD4 count, ART eligibility, and start of ART, by department of test, study phase, study site,
sex, and age; Rwanda, March–May 2009 (phase 1) and December 2009–February 2010 (phase 3).
Total
Number (%) of patients
enrolled into pre-ART care
≤90 days
Number (%) of
patients in WHO stage
3/4a
Median CD4 count in
cells/mm3 (IQR)b
Number (%) of ART-
eligible patientsc
Number (%) of eligible
patients who started ART
≤90 days
Total 635 232/635 (36.5) 43/217 (19.8) 384 (214–539) 93/208 (44.7) 48/93 (51.6)
Department, by
phase
OPD phase 1 73 32/73 (43.8) 7/28 (25.0) 287 (112–387) 16/27 (59.3) 11/16 (68.8)
OPD phase 3 125 37/125 (29.6) 7/37 (18.9) 312 (134–563) 19/35 (54.3) 10/19 (52.6)
VCT phase 1 237 92/237 (38.3) 12/85 (14.1) 398 (288–533) 30/81 (37.0) 16/30 (53.3)
VCT phase 3 200 71/200 (35.5) 17/67 (25.4) 431 (245–655) 28/65 (43.1) 11/28 (39.3)
p Valued .180 .317 .008 .132 .304
Study site
Muhoza 255 60/255 (23.5) 17/60 (28.3) 391 (260–560) 28/60 (46.7) 22/28 (78.6)
Ruhengeri 13 6/13 (46.2) 3/6 (50.0) 177 (97–440) 4/6 (66.7) 3/4 (75.0)
Kibagabaga 90 35/90 (38.9) 1/27 (3.7) 444 (262–568) 8/27 (29.6) 8/8 (100.0)
Kinyinya 92 38/92 (41.3) 9/37 (24.3) 367 (276–702) 15/31 (48.4) 5/15 (33.3)
Kimironko 158 78/158 (49.4) 10/72 (13.9) 358 (154–533) 32/69 (46.4) 5/32 (15.6)
Rwaza 27 15/27 (55.6) 3/15 (20.0) 369 (215–408) 6/15 (40.0) 5/6 (83.3)
p Valued <.001 .017 .306 .537 <.001
Sex
Male 243 92/243 (37.9) 18/86 (20.9) 311 (154–484) 45/82 (54.9) 27/46 (58.7)
Female 392 140/392 (35.7) 25/131 (19.1) 422 (269–605) 48/126 (38.1) 21/47 (44.7)
p Valued .585 .739 .003 .017 .176
Age group
15–24 years 160 58/160 (36.3) 9/55 (16.4) 487 (288–660) 18/53 (34.0) 7/18 (38.9)
25–34 years 254 92/254 (36.2) 14/84 (16.7) 385 (222–582) 36/81 (44.4) 18/36 (50.0)
35–44 years 122 44/122 (36.1) 10/42 (23.8) 317 (109–435) 22/39 (56.4) 10/22 (45.5)
≥45 years 90 38/90 (42.2) 10/36 (27.8) 360 (215–453) 17/35 (48.6) 13/17 (76.5)
p Valued .753 .415 .011 .183 .125
Notes: Those aged <15 were excluded from the analyses. Significant p values have presented in bold. ART, antiretroviral therapy; HIV, human immunodeficiency
virus; IQR, interquartile range; OPD, out-patient department; VCT, voluntary counselling and testing; WHO, World Health Organization.
aWHO stage was available for 217/232.
bCD4 count results were available for 218/232.
cART eligibility was based on CD4 count (CD4 < 350 cells/mm3) and WHO stage (stage 4) which were available for 208/232 patients.
dThe p values are based on Chi-squared test, Fisher’s exact test, or Kruskal–Wallis test, as appropriate.
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PITC. Several studies report that operational problems
such as increased waiting times are common under
PITC (Evans & Ndirangu, 2009; Roura et al., 2013;
Topp et al., 2010). This could also have led to lower link-
age-to-pre-ART-care after PITC in this study. Problems
with health services were one of the main barriers
towards linkage-to-care reported by patients in this
study. Higher workload and longer consultation time
under PITC were reported by heath staff, as previously
discussed (Kayigamba et al., 2014).
However, our findings should be interpreted with
caution. The proportion of patients enrolling into pre-
ART care in this study, both at the VCT and OPD
departments before as well as after the introduction of
PITC, was among the lowest reported in SSA (Kranzer
et al., 2012; Mutimura et al., 2014; Rosen & Fox, 2011).
Our survey among patients who were not registered at
the ART clinic demonstrated that this proportion was
an underestimate of patients actually linked to pre-
ART care. This survey showed that over one-third of
these non-registered patients had in fact enrolled at a
different HF or, perhaps surprisingly, had already
enrolled in HIV care prior to their diagnosis in this
study. It is likely that these factors may have also led to
underestimates of patients linking to pre-ART care in
other studies from SSA, as in many places no tracking
system is operational to track patients after an HIV diag-
nosis (Bassett et al., 2010; Rosen & Fox, 2011).
Retesting for HIV appears to happen frequently,
among non-enrolled patients and patients already
enrolled into HIV care. Under PITC a previous HIV
diagnosis and enrolment in care might not be communi-
cated to the HCW. Different research by our group
(Kayigamba et al., 2012, 2014) found that before the
introduction of PITC the most common reason for test-
ing was the desire to know one’s HIV status, while after-
wards this was because one was offered a test. Some
patients reported an HIV-negative test after their initial
positive test when they were tested at a different facility.
False positive rapid-test results have been reported in the
literature (Anzala et al., 2008; Gray et al., 2007; Kagulire
et al., 2011; Klarkowski et al., 2009), but operational
issues, such as non-observance of standard operating
procedures and lack of quality control, might also play
a role (Shanks, Klarkowski, & O’Brien, 2013).
Our findings should be viewed in the wider context of
a strong present HIV/AIDS stigma. Difficulty in accept-
ing their test result and fear of being seen at the HF were
main barriers towards enrolment in pre-ART care men-
tioned by patients in this study and also resulted in them
repeating HIV testing. Other studies have reported that
denial of HIV status and fear of HIV stigma can result
in non-engagement in care and decreased quality of
life (Beer, Fagan, Valverde, & Bertolli, 2009; Kamen
et al., 2012; Nakigozi et al., 2013; Weaver et al., 2004).
This studywas subject to certain limitations.Missing or
non-matching data betweenHF registers (names, age, sex,
initial department of consultation) resulted in the exclu-
sion of 9% of patients. The survey was held among a rela-
tively small sample of patients from phase 3. We were
Table 2. Factors associated with non-enrolment among adult HIV patients diagnosed in VCT or OPD department of six Rwanda HFs,
March–May 2009 (phase 1) and December 2009–February 2010 (phase 3); univariable and multivariable logistic regression.
n/N (%) OR (95% CI) p Value aOR (95% CI) p Value
Total 403/635 (63.5)
Department, by phase .177 .061
OPD phase 1 41/73 (56.2) 1 1
OPD phase 3 88/125 (70.4) 1.9 (1.0–3.4) 2.0 (1.0–4.2)
VCT phase 1 145/237 (61.2) 1.2 (0.7–2.1) 1.1 (0.6–2.1)
VCT phase 3 129/200 (64.5) 1.4 (0.8–2.4) 1.3 (0.6–2.5)
Study site <.001 <.001
Muhoza 195/255 (76.5) 1 1
Ruhengeri 7/13 (53.9) 0.4 (0.1–1.1) 0.3 (0.1–0.9)
Kibagabaga 55/90 (61.1) 0.5 (0.3–0.8) 0.5 (0.3–0.8)
Kinyinya 54/92 (58.7) 0.4 (0.3–0.7) 0.4 (0.2–0.7)
Kimironko 80/158 (50.6) 0.3 (0.2–0.5) 0.3 (0.2–0.4)
Rwaza 12/27 (44.4) 0.2 (0.1–0.6) 0.3 (0.1–0.7)
Sex .586 .813
Female 252/392 (64.3) 1 1
Male 151/243 (62.1) 0.9 (0.7–1.3) 1.0 (0.7–1.5)
Age .756 .678
15–24 years 102/160 (63.8) 1.3 (0.7–2.3) 1.3 (0.7–2.3)
25–34 years 162/254 (63.8) 1.3 (0.8–2.1) 1.3 (0.8–2.2)
35–44 years 78/122 (63.9) 1.3 (0.7–2.3) 1.4 (0.8–2.6)
≥45 years 52/90 (57.8) 1 1
Notes: Those aged <15 years were excluded from the analyses. aOR, adjusted odds ratio; HIV, human immunodeficiency virus; OPD, out-patient department; VCT,
voluntary counselling and testing; OR, odds ratio; 95% CI, 95% confidence interval.
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unable to explore differences in reported barriers before
and after the introduction of PITC and the power to find
significant differences between VCT and OPD depart-
ments was limited. A key strength of our study is that we
used routine data from primary care clinics and hospitals,
reflecting routine healthcare practice. Another strength is
that we triangulated our findings from the hospital regis-
ters with data from a survey among non-enrolled patients,
through which we were able to explore patient-reported
barriers towards linkage-to-HIV-care.
Figure 2. (a) Time to enrolment at ART clinic among 635 HIV
patients from the date of HIV diagnosis. (b) Time to start ART
among 93 eligible HIV patients, from the date of HIV diagnosis.
(c) Time to start ART among 93 eligible HIV patients, from the date
of CD4 count. Rwanda, March–May 2009 (phase 1) and December
2009–February 2010 (phase 3). ART = antiretroviral therapy; HIV =
human immunodeficiency virus; 95% CI = 95% confidence interval.
Table 3. Characteristics of 60 survey respondents who were not
enrolled into pre-ART care in phase 3 of the study, their
enrolment status at the time of the survey, and reason(s) for
non-enrolment, Rwanda, August 2010.
All patients
N = 60
VCT patients
N = 34
Out-
patients
N = 26
P
Valuea
Median age (IQR) 32 (25–40) 30 (25–40) 37 (25–45) .379
Sex N (%) N (%) N (%) .362
Male 26 (43) 13 (38) 13 (50)
Female 34 (57) 21 (62) 13 (50)
Education .609
None 10 (17) 5 (15) 5 (19)
Primary 39 (65) 24 (71) 15 (58)
Secondary 10 (17) 5 (15) 5 (19)
Vocational training 1 (2) 0 (0) 1 (4)
Site <.001
Muhoza 27 (45) 20 (59) 7 (27)
Ruhengeri 5 (8) 0 (0) 5 (19)
Kibagabaga 5 (8) 0 (0) 5 (19)
Kinyinya 10 (17) 8 (24) 2 (8)
Kimironko 9 (15) 4 (12) 5 (19)
Rwaza 4 (7) 2 (6) 2 (8)
Enrolled into pre-
ART care at the
time of survey
.644
Yes, before they took
the HIV (re)test in
phase 3
14 (23) 10 (29) 4 (15)
Yes, at a different HF 10 (17) 5 (15) 5 (19)
Yes, at the same HF 2 (3) 1 (3) 1 (4)
No 34 (57) 18 (53) 16 (62)
Reason(s) for not
enrolling into pre-
ART careb
N = 34 N = 18 N = 16 .485
Due to problems
with the service at
the HF
8 (24) 6 (33) 2 (13)
Fear of the
consequences of
disclosing HIV
status
8 (24) 2 (11) 6 (38)
Difficulties accepting
or mistrusting the
test result
7 (21) 4 (22) 3 (19)
Negative HIV test at
different HF
5 (15) 4 (22) 1 (6)
No time to come
back to the clinic
4 (12) 1 (6) 3 (19)
Feeling healthy, do
not see the need
4 (12) 2 (11) 2 (13)
Believe that prayers
can cure HIV
3 (9) 2 (11) 1 (6)
Not seeing the
benefit of taking
ART
3 (9) 2 (11) 1 (6)
Otherc 4 (12) 3 (17) 1 (6)
Notes: ART, antiretroviral therapy; HIV, human immunodeficiency virus; IQR,
interquartile range; VCT, voluntary counselling and testing.
aThe p values are based on Chi-squared test, Fisher’s exact test, or Kruskal–
Wallis test, as appropriate.
bMore reasons per person could be given.
cThe other four reasons given were: due to a misunderstanding with the hus-
band; lacking the willingness; lost health insurance card; and too old to act
upon the problem.
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In conclusion, the introduction of PITC in the OPD
may have had a negative impact on linkage-to-HIV-
care in Rwandan HFs. Healthier patients tested through
PITC might be less ready to engage in HIV care. Fear of
HIV stigma and mistrust of test results appear to be at
the root of these problems.
Acknowledgements
We would like to thank all study participants, INTERACT
staff, clinic staff of participating health facilities and commu-
nity workers. We thank Frank Cobelens for his feedback on
a draft of this manuscript.
MSVDL, MB, and FK designed the study and AA, EB, and
VM advised on the study concept and design. FK, EB, and CF
led the data collection and all authors advised on data collec-
tion. CF did the main quantitative and qualitative analyses,
MSVDL advised on quantitative analysis and KM on qualitat-
ive design and analysis. All authors contributed to the
interpretation of findings. CF wrote the first draft of the manu-
script, all authors made critical revisions, and all approved the
final version.
Funding
This work was supported by the Netherlands Organization for
Scientiﬁc Research/Netherlands Foundation for the Advance-
ment of Tropical Research (NWO-WOTRO/NACCAP)
[grant number W070520100] and the European Union
[grant number SANTE/2006/105-316].
References
Anzala, O., Sanders, E. J., Kamali, A., Katende, M., Mutua, G.
N., Ruzagira, E.… , Price, M. (2008). Sensitivity and speci-
ficity of HIV rapid tests used for research and voluntary
counselling and testing. The East African Medical Journal,
85, 500–504.
Bassett, I. V., Regan, S., Chetty, S., Giddy, J., Uhler, L. M.,
Holst, H.… Losina, E. (2010). Who starts antiretroviral
therapy in Durban, South Africa?… not everyone who
should. AIDS, 24(Suppl. 1), S37–S44.
Beer, L., Fagan, J. L., Valverde, E., & Bertolli, J. (2009). Health-
related beliefs and decisions about accessing HIV medical
care among HIV-infected persons who are not receiving
care. AIDS Patient Care and STDs, 23, 785–792.
Boyatzis, R. (1998). Transforming qualitative information:
Thematic analysis and code development. Thousand Oaks,
CA: Sage.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T.,
Hosseinipour, M. C., Kumarasamy, N.,… Fleming, T. R.
(2011). Prevention of HIV-1 infection with early antiretro-
viral therapy. New England Journal of Medicine, 365, 493–
505.
De Cock, K. M., Fowler, M. G., Mercier, E., de Vincenzi, I.,
Saba, J., Hoff, E.,… Shaffer, N. (2000). Prevention of
mother-to-child HIV transmission in resource-poor
countries: Translating research into policy and practice.
JAMA, 283, 1175–1182.
Evans, C., & Ndirangu, E. (2009). The nursing implications of
routine provider-initiated HIV testing and counselling in
sub-Saharan Africa: A critical review of new policy guidance
from WHO/UNAIDS. International Journal of Nursing
Studies, 46, 723–731.
Govindasamy, D., Ford, N., & Kranzer, K. (2012). Risk factors,
barriers and facilitators for linkage to antiretroviral therapy
care: A systematic review. AIDS, 26, 2059–2067.
Gray, R. H., Makumbi, F., Serwadda, D., Lutalo, T., Nalugoda,
F., Opendi, P.,…Wawer, M. J. (2007). Limitations of rapid
HIV-1 tests during screening for trials in Uganda:
Diagnostic test accuracy study. BMJ, 335, 188.
Hensen, B., Baggaley, R., Wong, V. J., Grabbe, K. L., Shaffer,
N., Lo, Y. R. J., & Hargreaves, J. (2012). Universal volun-
tary HIV testing in antenatal care settings: A review of
the contribution of provider-initiated testing & counsel-
ling. Tropical Medicine & International Health, 17,
59–70.
Kagulire, S. C., Opendi, P., Stamper, P. D., Nakavuma, J. L.,
Mills, L. A., Makumbi, F.,… Reynolds, S. J. (2011). Field
evaluation of five rapid diagnostic tests for screening of
HIV-1 infections in rural Rakai, Uganda. International
Journal of STD & AIDS, 22, 308–309.
Kamen, C., Taniguchi, S., Student, A., Kienitz, E., Giles, K.,
Khan, C.,… Koopman, C. (2012). The impact of denial on
health-related quality of life in patients with HIV. Quality
of Life Research, 21, 1327–1336.
Kayigamba, F. R., Bakker, M. I., Fikse, H., Mugisha, V.,
Asiimwe, A., & Schim van der Loeff, M. (2012). Patient
enrolment into HIV care and treatment within 90 days of
HIV diagnosis in eight Rwandan health facilities: A review
of facility-based registers. PLoS One, 7, e36792.
Kayigamba, F. R., Bakker, M. I., Lammers, J., Mugisha, V.,
Bagiruwigize, E., Asiimwe, A., & van der Loeff, M. F. S.
(2014). Provider-initiated HIV testing and counselling in
Rwanda: Acceptability among clinic attendees and workers,
reasons for testing and predictors of testing. PLoS One, 9,
e95459.
Kennedy, C. E., Fonner, V. A., Sweat, M. D., Okero, F. A.,
Baggaley, R., & O’Reilly, K. R. (2013). Provider-initiated
HIV testing and counseling in low- and middle-income
countries: A systematic review. AIDS and Behavior, 17,
1571–1590.
Klarkowski, D. B., Wazome, J. M., Lokuge, K. M., Shanks, L.,
Mills, C. F., & O’Brien, D. P. (2009). The evaluation of a
rapid in situ HIV confirmation test in a programme with
a high failure rate of the WHO HIV two-test diagnostic
algorithm. PLoS One, 4, e4351.
Kranzer, K., Govindasamy, D., Ford, N., Johnston, V., & Lawn,
S. D. (2012). Quantifying and addressing losses along the
continuum of care for people living with HIV infection in
sub-Saharan Africa: A systematic review. Journal of the
International AIDS Society, 15, 17383.
Lankowski, A. J., Siedner, M. J., Bangsberg, D. R., & Tsai, A. C.
(2014). Impact of geographic and transportation-related
barriers on HIV outcomes in sub-Saharan Africa: A sys-
tematic review. AIDS and Behavior, 18, 1199–1223.
McNairy, M. L., & El Sadr, W. M. (2012). The HIV care con-
tinuum: No partial credit given. AIDS, 26, 1735–1738.
Mutimura, E., Addison, D., Anastos, K., Hoover, D.,
Dusingize, J., Karenzi, B.,…Nash, D. (2014). Trends in
and determinants of CD4+ cell count at antiretroviral
AIDS CARE 333
therapy initiation after changes in national ART guidelines
in Rwanda. AIDS, 29(1), 67–76.
Nakigozi, G., Atuyambe, L., Kamya, M., Makumbi, F. E.,
Chang, L. W., Nakyanjo, N.,…Gray, R. (2013). A qualitat-
ive study of barriers to enrollment into free HIV care:
Perspectives of never-in-care HIV-positive patients and
providers in Rakai, Uganda. BioMed Research
International, 2013, ID 470245.
National Institute of Statistics of Rwanda. (2006). Rwanda
demographic and health survey 2005. Calverton, MD:
INSR and ORC Macro.
National Institute of Statistics of Rwanda. (2008). Rwanda
service provision assessment survey 2007. Calverton, MD:
NIS, MOH, and Macro International.
National Institute of Statistics of Rwanda. (2012). Rwanda
demographic and health survey 2010. Calverton, MD:
NISR, MOH, and ICF International.
Palella, F. J. J., Delaney, K. M., Moorman, A. C., Loveless, M.
O., Fuhrer, J., Satten, G. A.,…Holmberg, S. D. (1998).
Declining morbidity and mortality among patients with
advanced human immunodeficiency virus infection. HIV
outpatient study investigators. New England Journal of
Medicine, 338, 853–860.
Rosen, S., & Fox, M. P. (2011). Retention in HIV care between
testing and treatment in sub-Saharan Africa: A systematic
review. PLoS Medicine, 8, e1001056.
Roura, M., Watson-Jones, D., Kahawita, T. M., Ferguson, L., &
Ross, D. A. (2013). Provider-initiated testing and counsel-
ling programmes in sub-Saharan Africa: A systematic
review of their operational implementation. AIDS, 27,
617–626.
Shanks, L., Klarkowski, D., & O’Brien, D. P. (2013). False posi-
tive HIV diagnoses in resource limited settings: Operational
lessons learned for HIV programmes. PLoS One, 8, e59906.
Siegfried, N., van der Merwe, L., Brocklehurst, P., & Sint, T. T.
(2011). Antiretrovirals for reducing the risk of mother-to-
child transmission of HIV infection. Cochrane Database of
Systematic Reviews, 2011(1), CD003510.
Topp, S. M., Chipukuma, J. M., Giganti, M., Mwango, L. K.,
Chiko, L. M., Tambatamba-Chapula, B.,… Reid, S. (2010).
Strengthening health systems at facility-level: Feasibility of
integrating antiretroviral therapy into primary health care
services in Lusaka, Zambia. PLoS One, 5, e11522.
Trac-plus (2009). Guidelines for the provision of comprehensive
care to persons infected by HIV in Rwanda. Kigali: Ministry
of Health.
Varni, S., Miller, C., McCuin, T., & Solomon, S. (2012).
Disengagement and engagement coping with HIV/AIDS
stigma and psychological well-being of people with HIV/
AIDS. Journal of Social and Clinical Psychology, 31, 123–150.
Weaver, K. E., Antoni, M. H., Lechner, S. C., Duran, R. E. F.,
Penedo, F., Fernandez, M. I.,… Schneiderman, N. (2004).
Perceived stress mediates the effects of coping on the quality
of life of HIV-positive women on highly active antiretroviral
therapy. AIDS and Behavior, 8, 175–183.
World Health Organization. (2007). Guidance on provider-
initiated HIV testing and counselling in health facilities.
Strengthening health services to fight HIV/AIDS. Geneva:
Author.
World Health Organization. (2013). Global report on HIV
treatment 2013: Results, impact and opportunities. Geneva:
Author.
334 C. B. FRANSE ET AL.
